Clinical Trial Results:
A phase II, multi-center, non-randomized, open-label study of TKI258 in patients with relapsed or refractory multiple myeloma, who are with or without t(4;14) translocation
Summary
|
|
EudraCT number |
2009-012417-22 |
Trial protocol |
NL FR DE ES |
Global completion date |
12 Feb 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Oct 2016
|
First version publication date |
06 Oct 2016
|
Other versions |
|
Summary report(s) |
CTKI258A2204.CTR.06Sept2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.